Tissue Engineering Part A

Papers
(The H4-Index of Tissue Engineering Part A is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Toward the Development of a Tissue Engineered Gradient Utilizing CRISPR-Guided Gene Modulation74
Comparative Structural and Functional Analysis of Micronized Collagen-Based Scaffolds55
TERMIS 2023 – European Chapter Manchester Central Conference Centre Manchester, UK March 28–31, 202343
Effect of Microbial Stimuli and Bone Morphogenetic Protein 2 on Ectopic Bone Formation40
Optimized Biomanufacturing for Treatment of Volumetric Muscle Loss Enables Physiomimetic Recovery36
Cardiovascular Tissue Engineering and Regeneration: A Plead for Further Knowledge Convergence30
Bioprinting of a Liposomal Oxygen-Releasing Scaffold for Ovary Tissue Engineering30
Keratin 3D Printing: Sustainable Biomaterials for Regenerative Medicine and Biomanufacturing28
Human Induced Pluripotent Stem Cell Encapsulation Geometry Impacts Three-Dimensional Developing Human Engineered Cardiac Tissue Functionality28
Hematoxylin and Eosin Architecture Uncovers Clinically Divergent Niches in Pancreatic Cancer27
TGFβ-1 and Healing of Bone Defects in Large Animal and Rabbit Models: A Systematic Review22
Abstracts TERMIS EU Freiburg, Germany May 20–23, 202521
Regenerative Healing21
Abstracts20
Triply Periodic Minimal Surface-Based Scaffolds for Bone Tissue Engineering: A Mechanical, In Vitro and In Vivo 20
Bonegraft Using Octacalcium Phosphate Collagen Composite with Teriparatide and Polylactic Acid Cage20
Highly Porous Gas-Blown Hydrogels for Direct Cell Encapsulation with High Cell Viability19
Tricultured Cell Sheets Develop into Functional Pancreatic Islet Tissue with a Vascular Network19
A Multilayer Nanofibrous Mat for the Topical Chemotherapy of the Positive Margin in Bladder Cancer19
0.080832958221436